⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38726 | 0.83 | TDP1 (0.61) | — | |
| SCHEMBL11904537 | 0.83 | TDP1 (0.61) | — | |
| SCHEMBL18074258 | 0.80 | TDP1 (0.58) | — | |
| Fluoride SCHEMBL20513066 | 0.80 | TDP1 (0.58) | — | |
| SCHEMBL18074260 | 0.80 | TDP1 (0.58) | — | |
| SCHEMBL23727166 | 0.80 | TDP1 (0.58) | — | |
| Bromide SCHEMBL20513084 | 0.80 | TDP1 (0.58) | — | |
| Fluoride SCHEMBL21331933 | 0.80 | TDP1 (0.58) | — | |
| Ammonia Solution, Strong SCHEMBL16240294 | 0.80 | TDP1 (0.58) | — | |
| Ammonia Solution, Strong SCHEMBL16240292 | 0.80 | TDP1 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115804739-B | Qiu Jili fermented product, method for producing same, and use thereof | 百岳特生物技术（上海）有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-112844487-B | Alkali lignin supported metalloporphyrin catalyst and preparation method and application thereof | 南京工业大学 | 2023-01-24 | — | — | CN | claimed |
| CN-112844487-A | Alkali lignin supported metalloporphyrin catalyst and preparation method and application thereof | 南京工业大学 | 2021-05-28 | — | — | CN | claimed |
| CN-106892884-B | Method for preparing 5-HMF by catalyzing biomass sugar with oxidation product of 5-HMF | 天津工业大学 | 2020-02-21 | — | — | CN | claimed |
| US-7297168-B2 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2007-11-20 | — | — | US | claimed |
| US-20050198745-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | PROCTER & GAMBLE COMPANY, THE | 2005-09-15 | — | — | US | claimed |
| CN-115804739-B | Qiu Jili fermented product, method for producing same, and use thereof | 百岳特生物技术（上海）有限公司 | 2025-03-14 | — | — | CN | disclosed |
| WO-2024172198-A1 | ANODE COMPOSITE CATALYST, AND METHOD FOR PREPARING MALEIC ACID OR DERIVATIVE THEREOF BY USING SAME | 서울대학교산학협력단 | 2024-08-22 | — | — | WO | disclosed |
| CN-115109048-B | (hetero) aryl amide compound | 中国药科大学 | 2023-12-08 | — | — | CN | disclosed |
| CN-116685338-A | Compositions and methods for improving skin health and for treating and preventing diseases, disorders and conditions associated with fungi and other pathogenic microorganisms | 德慕拜昂生物科技公司 | 2023-09-01 | — | — | CN | disclosed |
| EP-4228665-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH FUNGI AND OTHER PATHOGENIC MICROBES | Dermbiont, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-112844487-B | Alkali lignin supported metalloporphyrin catalyst and preparation method and application thereof | 南京工业大学 | 2023-01-24 | — | — | CN | disclosed |
| CN-112844487-B | Alkali lignin supported metalloporphyrin catalyst and preparation method and application thereof | 南京工业大学 | 2023-01-24 | — | — | CN | disclosed |
| EP-1299409-B1 | 9.ALPHA.-CHLORO-6.ALPHA.-FLUORO-17.ALPHA.-HYDROXY-16-METHYL-17-BETA-METHOXYCARBONYL-ANDROST-1,4-DIENES ESTERIFIED IN POSITION 17.ALPHA. BY A CYCLIC ACYL GROUP | NOVARTIS AG (CH) | 2005-04-06 | — | — | EP | disclosed |
| CN-1439018-A | 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group | NOVARTIS AG (CH) | 2003-08-27 | — | — | CN | disclosed |
| US-20030158163-A1 | Organic compounds | NOVARTIS AG (CH) | 2003-08-21 | — | — | US | disclosed |
| EP-1299409-A2 | 9.ALPHA.-CHLORO-6.ALPHA.-FLUORO-17.ALPHA.-HYDROXY-16-METHYL-17-BETA-METHOXYCARBONYL-ANDROST-1,4-DIENES ESTERIFIED IN POSITION 17.ALPHA. BY A CYCLIC ACYL GROUP | Novartis AG (CH) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002000679-A2 | 9.ALPHA.-CHLORO-6.ALPHA.-FLUORO-17.ALPHA.-HYDROXY-16-METHYL-17-BETA-METHOXYCARBONYL-ANDROST-1,4-DIENES ESTERIFIED IN POSITION 17.ALPHA. BY A CYCLIC ACYL GROUP | NOVARTIS AG (CH) | 2002-01-03 | — | — | WO | disclosed |
| US-5750550-A | RESPIRATORY SYSTEM DISORDERS | SANOFI (FR) | 1998-05-12 | — | — | US | disclosed |
| WO-1997010243-A1 | 2-(PYRAZOL-5-YL-OXYMETHYL)-1,2-BENZISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANOFI (US) | 1997-03-20 | — | — | WO | disclosed |